“…( 14 ) Future clinical trial designs could incorporate new paradigms to address common challenges, considering various phases of injury and recovery, and no longer a pseudo-normalization of 2-year test-scores (see Table 3 for a summary of recommendations). ( 8 , 10 , 56 – 60 , 63 , 64 , 71 , 73 , 74 , 15 , 75 , 77 – 79 , 81 – 84 , 98 , 102 , 17 , 103 – 111 , 27 , 30 , 32 , 35 , 47 , 55 )…”